JD Health International Inc.
JDHIY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $35,290,047 | $29,815,920 | $28,343,961 | $26,419,605 |
| % Growth | 18.4% | 5.2% | 7.3% | – |
| Cost of Goods Sold | $26,398,129 | $23,207,286 | $21,644,018 | $20,757,269 |
| Gross Profit | $8,891,918 | $6,608,634 | $6,699,943 | $5,662,336 |
| % Margin | 25.2% | 22.2% | 23.6% | 21.4% |
| R&D Expenses | $736,385 | $685,420 | $645,015 | $609,631 |
| G&A Expenses | $611,506 | $733,983 | $685,057 | $560,801 |
| SG&A Expenses | $6,028,485 | $5,795,321 | $5,019,910 | $5,301,101 |
| Sales & Mktg Exp. | $1,809,154 | $1,644,464 | $1,404,267 | $730,030 |
| Other Operating Expenses | $0 | -$315,853 | $0 | $0 |
| Operating Expenses | $6,764,870 | $6,164,888 | $5,664,925 | $5,910,732 |
| Operating Income | $2,127,048 | $443,746 | $1,035,018 | -$248,396 |
| % Margin | 6% | 1.5% | 3.7% | -0.9% |
| Other Income/Exp. Net | $736,618 | $1,913,588 | $1,404,324 | $679,457 |
| Pre-Tax Income | $2,863,666 | $2,357,334 | $2,439,342 | $900,682 |
| Tax Expense | $272,319 | $234,698 | $404,964 | $281,234 |
| Net Income | $2,596,445 | $2,124,662 | $2,037,182 | $580,483 |
| % Margin | 7.4% | 7.1% | 7.2% | 2.2% |
| EPS | 0.82 | 0.68 | 0.65 | 0.18 |
| % Growth | 20.6% | 4.6% | 261.1% | – |
| EPS Diluted | 0.81 | 0.67 | 0.65 | 0.18 |
| Weighted Avg Shares Out | 3,205,488 | 3,139,952 | 3,139,952 | 3,188,615 |
| Weighted Avg Shares Out Dil | 3,189,783 | 3,155,701 | 3,155,701 | 3,188,615 |
| Supplemental Information | – | – | – | – |
| Interest Income | $804,395 | -$18,522 | $1,979,024 | $1,012,577 |
| Interest Expense | $0 | $152 | $8,042 | $5,098 |
| Depreciation & Amortization | $120,347 | $111,477 | $103,218 | $119,528 |
| EBITDA | $2,247,395 | $3,881,329 | $1,138,236 | -$4,670 |
| % Margin | 6.4% | 13% | 4% | -0% |